Importance The introduction of biological tumor necrosis factor inhibitors has improved the
treatment of rheumatoid arthritis (RA) but at a substantial cost. These drugs have been …

Objective. To explore the incidence of disability pension (DP) due to RA as an estimation of
permanent work disability before and after introduction of biologic drugs. Methods. The …

Objectives Methotrexate (MTX) is administered once or thrice weekly to patients with
rheumatoid arthritis (RA). Even though RA continually progresses, MTX is not administered …

Recent years have witnessed a shift in the therapeutic approach for patients with early
rheumatoid arthritis (RA). The focus of interest has been the improved outcomes achieved …

Purpose: In this manuscript, we evaluated the effectiveness of an intervention programme
consisting of integrated care and a participatory workplace intervention on supervisor …

Objective: To assess the effect of 12-month treatment with adalimumab on work ability,
quality of life, and fatigue in patients with active rheumatoid arthritis (RA). Methods: One …

Objective The direct cost of relapsed or refractory multiple myeloma (RRMM) is documented;
indirect costs are being explored. Healthcare payers seek cost‐offsets from therapies that …

Objectives Evaluating the cost effectiveness and cost utility of an integrated care intervention
and participatory workplace intervention for workers with rheumatoid arthritis (RA) to …

With the establishment of the new American College of Rheumatology/European League
Against Rheumatism (ACR/EULAR) 2010 criteria for rheumatoid arthritis (RA) to diagnose …

Objectives: To assess the relationship between disease activity and work ability, quality of
life (QoL), and fatigue in patients with RA during a 12-month course of the tumour necrosis …